Inclusion Criteria:

   1. Parent guardian must be able to understand and provide informed consent per
   Institutional Review Board (IRB) guidelines and regulations.

   2. Male or female participants, between the ages of 0 to 40 years will be included

   3. Diagnosis of moderate to severe active AD (Scoring Atopic Dermatitis (SCORAD) score >
   26) without a history or current manifestations of eczema herpeticum (EH)

   4. AD affecting at least 3 different skin areas (contralateral arms and one lower
   extremity)

Exclusion Criteria:

   1. Inability or unwillingness of a parent guardian to give written informed consent, or
   to comply with study protocol.

   2. Participants with skin disease other than AD that might compromise the stratum corneum
   barriers (e.g., bullous diseases, psoriasis, cutaneous T-cell lymphoma (also called
   Mycosis Fungoides or Sezary syndrome], dermatitis herpetiformis, Hailey-Hailey, or
   Darier's disease).

   3. Known or suspected immunosuppression

   4. Severe concomitant illness(es)

   5. History of serious life-threatening reaction to latex, tape, or adhesives

   6. Has received total body phototherapy (e.g., ultraviolet light B [UVB], psoralen
   ultraviolet light A [PUVA], tanning beds [>1 visit per week]) within 30 days of the
   Enrollment Visit

   7. Use of topical corticosteroids, topical immunomodulatory agents (such as calcineural
   inhibitors and crisaborole), or topical antibiotics on the upper or lower extremities
   within 7 days of the Enrollment Visit

   8. Has taken a bleach bath within 7 days of the Enrollment Visit

   9. Use of systemic antibiotics, antiparasitics, antivirals, or antifungals within 7 days
   of the Enrollment Visit.